生物活性 | |||
---|---|---|---|
描述 | eCF506 is a potent, orally active inhibitor of the non-receptor tyrosine kinase Src, with an IC50 value of <0.5 nM. eCF506 inhibits the phosphorylation of SRC and FAK at low nanomolar levels, with complete inhibition of phosphorylation at 100 nM. eCF506 inhibits only SFK, with sub-nanomolar IC50 values for SRC and YES (IC50=0.5, 2.1 nM). It is noted that eCF506 shows a large difference in activity between ABL and its primary target, SRC (>950-fold difference)[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.96mL 0.39mL 0.20mL |
9.79mL 1.96mL 0.98mL |
19.58mL 3.92mL 1.96mL |
参考文献 |
---|